Dian Diagnostics In-licenses Metabolon’s Metabolomics Platform
February 07, 2017 at 06:51 AM EST
Zhejiang Dian Diagnostics, one of China ’s largest chains of independent medical laboratories, has entered into a joint laboratory licensing agreement with Metabolon, a metabolomics company based in North Carolina . Under the terms of the agreement, Dian will install Metabolon’s proprietary Discovery HD4™ platform in its new, state-of-the-art laboratory in Hangzhou and use its extensive market presence to commercialize Metabolon’s metabolomics-based products and services throughout China . Financial and other terms of the agreement were not disclosed. More details.... Stock Symbol (SHE: 300244) Share this with colleagues: // //